Back

Intravenous immunoglobulin combined with glucocorticoids for immune checkpoint inhibitor-induced fulminant myocarditis: a retrospective cohort study

29 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Acute myocarditis: from mechanisms to prognosis Acute Myocarditis ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Dao Wen Wang

Tongji Hospital- Tongji Medical College, Wuhan (China)

6 More presentations in this session

Presentation thumbnail
Diagnostic yield of etiologic workup in acute myocarditis: insights from the AMPHIBIA Registry
Doctor M. Proust (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Acute myocarditis and genetic testing: real-world practice before ESC guidance
Doctor C. Santos Jorge (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
External validation of a contemporary risk stratification model in acute myocarditis: prognostic implications from the PRE-MYO cohort
Doctor A. Fuentes Vivero (A Coruna, ES)
Abstract Slides Video
Presentation thumbnail
Midwall late gadolinium enhancement predicts adverse outcomes in pediatric myocarditis
Doctor A. Dennee (Houston, US)
Abstract Slides Video
Presentation thumbnail
Beyond ejection fraction: myocardial strain as a predictor of symptomatic recurrence in myocarditis
Doctor A. Esteban Fernandez (Leganes, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Acute myocarditis: from mechanisms to prognosis

The Event

Event poster

ESC Congress 2026

29 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Real-world cardiovascular toxicity of immune checkpoint inhibitors in an asian population: insights from a nationwide taiwanese registry
28 August 2026
thumbnail
Congress Presentation
Long-term effects of myocardial injury on one-year outcomes in COVID-19 survivors: a prospective cohort study
28 August 2026
thumbnail
Congress Presentation
Myocarditis - get ready for the session
2 September 2024
thumbnail
Congress Presentation
From immunosuppression to innovation: the new treatment landscape for inflammatory cardiomyopathy
31 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources